thymidine has been researched along with Cystic Fibrosis of Pancreas in 22 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report the isolation of thymidine-dependent small-colony variants (TD-SCVs) of Staphylococcus aureus from unusual infection sites of patients with chronic soft tissue infection, tympanitis, bronchitis, peritonitis, and septicemia." | 7.74 | Thymidine-dependent Staphylococcus aureus small-colony variants: human pathogens that are relevant not only in cases of cystic fibrosis lung disease. ( Besier, S; Brade, V; Ehrhart, A; Hunfeld, KP; Saum, SH; Siegel, E; Wichelhaus, TA; Zander, J, 2008) |
| "During a 1-year period, the prevalence of thymidine-dependent (TD) Staphylococcus aureus in patients at two geographically distinct cystic fibrosis (CF) centers was determined." | 7.67 | Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis. ( Gage, PA; Gilligan, PH; Muszynski, MJ; Wait, KR; Welch, DF, 1987) |
| "Cystic fibrosis is a monogenic recessive disorder found predominantly in Caucasian population." | 5.38 | Poly thymidine polymorphism and cystic fibrosis in a non-Caucasian population. ( Bazzaz, JT; Douki, MR; Larijani, B; Niaki, HA; Tabaripour, R; Yaghmaei, P, 2012) |
| " The activities of oxacillin, fusidic acid, clindamycin, gentamicin, rifampin, vancomycin, linezolid, quinupristin-dalfopristin, daptomycin, tigecycline, moxifloxacin, telavancin, and oritavancin have been examined in THP-1 macrophages infected by a stable thymidine-dependent SCV strain in comparison with normal-phenotype and revertant isogenic strains isolated from the same cystic fibrosis patient." | 3.75 | Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype a ( Denis, O; Nguyen, HA; Struelens, MJ; Theunis, A; Tulkens, PM; Van Bambeke, F; Vergison, A, 2009) |
| "We report the isolation of thymidine-dependent small-colony variants (TD-SCVs) of Staphylococcus aureus from unusual infection sites of patients with chronic soft tissue infection, tympanitis, bronchitis, peritonitis, and septicemia." | 3.74 | Thymidine-dependent Staphylococcus aureus small-colony variants: human pathogens that are relevant not only in cases of cystic fibrosis lung disease. ( Besier, S; Brade, V; Ehrhart, A; Hunfeld, KP; Saum, SH; Siegel, E; Wichelhaus, TA; Zander, J, 2008) |
| "Trimethoprim-sulfamethoxazole (SXT)-resistant Staphylococcus aureus thymidine-dependent small-colony variants (TD-SCVs) are frequently isolated from the airways of cystic fibrosis (CF) patients, often in combination with isogenic normal strains if patients were treated with SXT for extended periods." | 3.74 | In vivo mutations of thymidylate synthase (encoded by thyA) are responsible for thymidine dependency in clinical small-colony variants of Staphylococcus aureus. ( Chatterjee, I; Deiwick, S; Fischer, A; Herrmann, M; Kahl, BC; Kriegeskorte, A; Peters, G; Proctor, RA; Theimann, N, 2008) |
| "Thymidine-dependent small-colony variants (SCVs) of Staphylococcus aureus are frequently associated with persistent and recurrent infections in cystic fibrosis patients." | 3.74 | Influence of dTMP on the phenotypic appearance and intracellular persistence of Staphylococcus aureus. ( Besier, S; Brade, V; Dehghani, F; Loitsch, S; Saum, SH; Wichelhaus, TA; Zander, J, 2008) |
| "Thymidine-dependent small-colony variants (TD-SCVs) of Staphylococcus aureus can be isolated from the airway secretions of patients suffering from cystic fibrosis (CF) and are implicated in persistent and treatment-resistant infections." | 3.74 | The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates. ( Besier, S; Brade, V; Kahl, BC; Kraiczy, P; Wichelhaus, TA; Zander, J, 2008) |
| "The study's purpose was to understand the molecular basis for different clinical phenotypes of the 5T variant, a tract of 5 thymidines in intron 8 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, which disrupts processing of CFTR mRNA and reduces synthesis from the corresponding CFTR alleles." | 3.73 | CFTR 5T variant has a low penetrance in females that is partially attributable to its haplotype. ( Anderson, B; Anguiano, A; Buller, A; Hantash, F; Huang, S; McGinniss, MJ; Milunsky, A; Quan, F; Redman, J; Strom, C; Sun, W, 2006) |
| "During a 1-year period, the prevalence of thymidine-dependent (TD) Staphylococcus aureus in patients at two geographically distinct cystic fibrosis (CF) centers was determined." | 3.67 | Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis. ( Gage, PA; Gilligan, PH; Muszynski, MJ; Wait, KR; Welch, DF, 1987) |
| "Cultured skin fibroblasts derived from unrelated patients with diagnosed cystic fibrosis were compared with those from one normal individual in respect to thymidine and uridine uptake." | 3.66 | Nucleoside uptake in normal and cystic fibrosis fibroblasts in vitro. ( Limbosch, S; Poliard, A; Van Geffel, R, 1980) |
| "Cystic fibrosis is a monogenic recessive disorder found predominantly in Caucasian population." | 1.38 | Poly thymidine polymorphism and cystic fibrosis in a non-Caucasian population. ( Bazzaz, JT; Douki, MR; Larijani, B; Niaki, HA; Tabaripour, R; Yaghmaei, P, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (31.82) | 18.7374 |
| 1990's | 1 (4.55) | 18.2507 |
| 2000's | 9 (40.91) | 29.6817 |
| 2010's | 3 (13.64) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| de Souza, DC | 2 |
| Cogo, LL | 2 |
| Palmeiro, JK | 2 |
| Dalla-Costa, LM | 2 |
| de Oliveira Tomaz, AP | 1 |
| Riedi, CA | 2 |
| Rosario Filho, NA | 2 |
| Tomaz, APO | 1 |
| Conte, D | 1 |
| Delgado-Valverde, M | 1 |
| Fernández-Echauri, P | 1 |
| Batista-Díaz, N | 1 |
| Pascual-Hernández, A | 1 |
| Tkadlec, J | 1 |
| Vařeková, E | 1 |
| Pantůček, R | 1 |
| Doškař, J | 1 |
| Růžičková, V | 1 |
| Botka, T | 1 |
| Fila, L | 1 |
| Melter, O | 1 |
| Besier, S | 3 |
| Zander, J | 3 |
| Siegel, E | 1 |
| Saum, SH | 2 |
| Hunfeld, KP | 1 |
| Ehrhart, A | 1 |
| Brade, V | 3 |
| Wichelhaus, TA | 3 |
| Nguyen, HA | 1 |
| Denis, O | 1 |
| Vergison, A | 1 |
| Theunis, A | 1 |
| Tulkens, PM | 1 |
| Struelens, MJ | 1 |
| Van Bambeke, F | 1 |
| Tabaripour, R | 1 |
| Niaki, HA | 1 |
| Douki, MR | 1 |
| Bazzaz, JT | 1 |
| Larijani, B | 1 |
| Yaghmaei, P | 1 |
| Disset, A | 1 |
| Michot, C | 1 |
| Harris, A | 1 |
| Buratti, E | 1 |
| Claustres, M | 1 |
| Tuffery-Giraud, S | 1 |
| Kahl, BC | 3 |
| Belling, G | 1 |
| Becker, P | 1 |
| Chatterjee, I | 2 |
| Wardecki, K | 1 |
| Hilgert, K | 1 |
| Cheung, AL | 1 |
| Peters, G | 2 |
| Herrmann, M | 2 |
| Cleeve, VJ | 1 |
| Perry, JD | 1 |
| Cresswell, G | 1 |
| Orr, KE | 1 |
| Sun, W | 1 |
| Anderson, B | 1 |
| Redman, J | 1 |
| Milunsky, A | 1 |
| Buller, A | 1 |
| McGinniss, MJ | 1 |
| Quan, F | 1 |
| Anguiano, A | 1 |
| Huang, S | 1 |
| Hantash, F | 1 |
| Strom, C | 1 |
| Kriegeskorte, A | 1 |
| Fischer, A | 1 |
| Deiwick, S | 1 |
| Theimann, N | 1 |
| Proctor, RA | 1 |
| Dehghani, F | 1 |
| Loitsch, S | 1 |
| Kraiczy, P | 1 |
| Limbosch, S | 1 |
| Poliard, A | 1 |
| Van Geffel, R | 1 |
| Strasberg, PM | 1 |
| Noreau, D | 1 |
| McGlynn-Steele, L | 1 |
| Koultchitski, G | 1 |
| Ray, PN | 1 |
| George, RH | 1 |
| Healing, DE | 1 |
| Sparham, PD | 1 |
| Lobban, DI | 1 |
| Speller, DC | 1 |
| Lam, LF | 1 |
| Shapiro, BL | 1 |
| Barranco, SC | 1 |
| Bolton, WE | 1 |
| Haenelt, BR | 1 |
| Abell, CW | 1 |
| Gilligan, PH | 1 |
| Gage, PA | 1 |
| Welch, DF | 1 |
| Muszynski, MJ | 1 |
| Wait, KR | 1 |
| Houck, JC | 1 |
| Cheng, FL | 1 |
22 other studies available for thymidine and Cystic Fibrosis of Pancreas
| Article | Year |
|---|---|
Thymidine-auxotrophic Staphylococcus aureus small-colony variant bacteremia in a patient with cystic fibrosis.
Topics: Anti-Bacterial Agents; Bacteremia; Cystic Fibrosis; Drug Resistance, Bacterial; Genes, Bacterial; Ge | 2020 |
Emergence of Thymidine-Dependent Staphylococcus aureus Small-Colony Variants in Cystic Fibrosis Patients in Southern Brazil.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; Brazil; Child; Child, Preschool; | 2021 |
[Small-colony variants of Staphylococcus aureus: Usefulness of various test for diagnosis and susceptibility study].
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Clone Cells; Colony Count, Microbial; Culture Med | 2014 |
Characterization of Staphylococcus aureus Strains Isolated from Czech Cystic Fibrosis Patients: High Rate of Ribosomal Mutation Conferring Resistance to MLS(B) Antibiotics as a Result of Long-Term and Low-Dose Azithromycin Treatment.
Topics: Anti-Bacterial Agents; Azithromycin; Cross Infection; Cystic Fibrosis; Czech Republic; Drug Resistan | 2015 |
Thymidine-dependent Staphylococcus aureus small-colony variants: human pathogens that are relevant not only in cases of cystic fibrosis lung disease.
Topics: Adult; Bronchitis; Child; Cystic Fibrosis; Female; Humans; Male; Middle Aged; Peritonitis; Pneumonia | 2008 |
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype a
Topics: Anti-Bacterial Agents; Cell Line; Cystic Fibrosis; Dose-Response Relationship, Drug; Fusidic Acid; G | 2009 |
Poly thymidine polymorphism and cystic fibrosis in a non-Caucasian population.
Topics: Adolescent; Base Sequence; Child; Child, Preschool; Cystic Fibrosis; Cystic Fibrosis Transmembrane C | 2012 |
A T3 allele in the CFTR gene exacerbates exon 9 skipping in vas deferens and epididymal cell lines and is associated with Congenital Bilateral Absence of Vas Deferens (CBAVD).
Topics: Adult; Alleles; Alternative Splicing; Caco-2 Cells; Cell Line; Cystic Fibrosis; Cystic Fibrosis Tran | 2005 |
Thymidine-dependent Staphylococcus aureus small-colony variants are associated with extensive alterations in regulator and virulence gene expression profiles.
Topics: Bacterial Proteins; Bacterial Toxins; Cystic Fibrosis; Gene Expression Profiling; Genes, Regulator; | 2005 |
Thymidine-dependent meticillin-resistant Staphylococcus aureus: a potentially unrecognized reservoir of MRSA in hospital patients?
Topics: Adult; Carrier State; Cystic Fibrosis; Humans; Male; Methicillin Resistance; Staphylococcal Infectio | 2006 |
CFTR 5T variant has a low penetrance in females that is partially attributable to its haplotype.
Topics: Alleles; Base Sequence; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female | 2006 |
In vivo mutations of thymidylate synthase (encoded by thyA) are responsible for thymidine dependency in clinical small-colony variants of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Culture Media; Cystic Fibrosis; Drug Resistance, Bacteria | 2008 |
Influence of dTMP on the phenotypic appearance and intracellular persistence of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cell Line; Cystic Fibrosis; Dihydropteroate Synthase; Fluorouracil; Folic Aci | 2008 |
The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cystic Fibrosis; Drug Resistance, Bacterial; Humans; Micr | 2008 |
Nucleoside uptake in normal and cystic fibrosis fibroblasts in vitro.
Topics: Cells, Cultured; Cystic Fibrosis; Fibroblasts; Humans; Nucleosides; Thymidine; Uridine | 1980 |
PCR-based test for two cystic fibrosis mutations (A455E, 711 + 1 G-->T) common among French Canadians.
Topics: Canada; Cystic Fibrosis; DNA Primers; France; Guanine; Humans; Introns; Mutation; Polymerase Chain R | 1997 |
Thymidine-requiring Haemophilus influenzae and Staphylococcus aureus.
Topics: Child; Culture Media; Cystic Fibrosis; Haemophilus influenzae; Humans; Sputum; Staphylococcus aureus | 1977 |
Thymidine-requiring Staphylococcus aureus.
Topics: Cystic Fibrosis; Drug Resistance, Microbial; Humans; Staphylococcus aureus; Thymidine; Trimethoprim | 1978 |
Differential incorporation of 3H-thymidine into DNA in cultured skin fibroblasts derived from patients with cystic fibrosis and controls.
Topics: Adolescent; Adult; Cell Division; Child; Cystic Fibrosis; DNA; Female; Fibroblasts; Humans; Male; Th | 1979 |
Differences in the incorporation of thymidine into DNA of normal and cystic fibrosis fibroblasts in vitro.
Topics: Bromodeoxyuridine; Cadmium; Cell Division; Cell Line; Cystic Fibrosis; DNA; Genotype; Kinetics; Thym | 1976 |
Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis.
Topics: Culture Media; Cystic Fibrosis; Drug Combinations; Humans; Respiratory System; Staphylococcus aureus | 1987 |
Defects in the cell cycle of fibroblasts obtained from patients with cystic fibrosis.
Topics: Autoradiography; Cell Division; Cell Line; Cells, Cultured; Culture Media; Cystic Fibrosis; Fibrobla | 1974 |